Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA miR-22 (MIR22) is a small non-coding RNA molecule that regulates gene expression post-transcriptionally. It plays a critical role in various cellular processes, including cancer biology and cardiac function, and can act as both a tumor suppressor and an oncogene depending on the context. Its expression is altered in various diseases, making it a potential biomarker and therapeutic target.
Binds to 3' UTR of target mRNAs, leading to mRNA degradation or translational repression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA miR-22 (MIR22).